PrintThe Burrill Report
G. Steven Burrill at the World Health Care Congress 2010.
December 21, 2010
http://www.burrillreport.com/article-why_you_will_soon_spit_on_your_blackberry.html
DIGITAL HEALTH
Why You Will Soon Spit on Your Blackberry
The Burrill Report's Publisher G. Steven Burrill discusses the transformation of medicine.[Please login to post comments]
- Sanofi-Aventis Signs $800 Million Cancer Drug Deal
Avila Therapeutics' targeted drug technology adds another arrow to Sanofi’s quiver for targeting cancer. Read More - Novartis Invests $500 million in Russia’s Healthcare Industry
Pharma will build a new manufacturing plant and expand its R&D; efforts in the country. Read More - REVA Medical Debuts—in Australia
Outlook for IPOs next year is hopeful. Read More - Prometheus Ruling Boosts Patents on Diagnostics
Podcast: December 27, 2010 Read More - Chronic Fatigue Alleged Culprit Questioned
New research shows virus linked to the disease is a lab contaminant. Read More - Brave Combo
Sanofi and Merck Serono to jointly study paired experimental cancer therapies as the FDA issues new guidance for codevelopment of two or more experimental drugs for use in combination. Read More - Pfizer and Adolor End Collaboration to Develop Pain Meds
The weekly round-up of failed trials, missed targets, and other business mishaps. Read More - Queensland’s Next Smart Move
Further growth of the industry will be facilitated by the establishment of a life sciences industry organization. Read More - Pondering Synthetic Biology's Future
Commission finds much work ahead to define boundaries, debate. Read More - Sanofi Taps Former NIH Head to Lead R&D;
Retooling aligns leadership with new development model. Read More
.gif)
.gif)
- Health Care Law Ruled Unconstitutional
The New york Times - Bayer to Spend $4.1 Billion on Research in 2011 as Xarelto Trials Near End
Bloomberg - Sanofi's chief gets U.S. lobby role as Kindler exits
Reuters - Pfizer’s Chairman and Chief Retires Unexpectedly
The New York Times - Arsenic-eating bacteria point to new life forms
The Scientist - Merck to buy SmartCells to gain diabetes product
Reuters - Overweight People, Not Just Obese, More Likely to Die Sooner, Study Says
Bloomberg - Orexigen Options Suggest Contrave Diet Pill May Avoid Arena, Vivus Delays
Bloomberg - Biosimilars will be challenging for FDA, speakers say
The Hill - EU guidelines clear way for biosimilar antibodies
Reuters